20.02.2013 Views

Drug Targeting Organ-Specific Strategies

Drug Targeting Organ-Specific Strategies

Drug Targeting Organ-Specific Strategies

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

dergo transcytosis [39] underlines the difference between vesicular transport and carrier-mediated<br />

uptake.<br />

Absorptive-mediated endocytosis and transcytosis of macromolecules through the BBB is<br />

related to receptor-mediated uptake, although not as specific. The process applies to certain<br />

lectins, for example wheat germ agglutinin [40], and to cationic proteins. Transport is triggered<br />

by glycoprotein binding (lectins) or by ionic interactions between negative charges on<br />

the endothelial plasma membrane and positive surface charges on the proteins. Both native<br />

proteins (histones) and chemically modified proteins (cationized albumin and IgG) can undergo<br />

absorptive-mediated transcytosis. While the physiological function of that process at<br />

the BBB remains to be identified, it offers a potential strategy for drug targeting/delivery<br />

[41].<br />

2.3.2 Techniques for Measurement of Brain Uptake<br />

2.3.2.1 In vivo Methods<br />

For the correct interpretation of brain uptake studies in general and for the pharmacokinetic<br />

validation of a given delivery strategy, it is necessary to be familiar with characteristics and<br />

limitations of the applied technique [41]. In vivo methods remain the gold standard, as there<br />

are still no cell culture models available that fully represent the barrier characteristics.<br />

Quantitative measurement of diffusional uptake and carrier-mediated transport of nutrients<br />

and drugs in experimental animals was greatly facilitated with the introduction of Oldendorf’s<br />

brain uptake index (BUI) [42]. Test and reference tracers are injected as an intraarterial<br />

bolus into the carotid artery of the anaesthetized animal. After 5 s the animal is killed<br />

and the brain is removed for radioactivity counting. This method measures the ratio of the<br />

unidirectional brain extraction, E, of the test substance and of the reference ([ 3 H]-water,<br />

[ 14 C]-butanol), which are labelled with different isotopes, during a single passage through the<br />

brain capillary bed:<br />

BUI = E test/E reference<br />

2.3 BBB Biology and Pharmacology 31<br />

(2.1)<br />

Advantages of the method include technical simplicity, and control over the composition<br />

of the injection fluid, making the technique suitable for competition and saturation experiments.<br />

Provided that the absolute value of E reference is known, the absolute E test may be calculated<br />

and, with the independently determined value of cerebral blood flow, F, E test may be<br />

converted into a permeability surface area (PS) product. The latter conversion follows from<br />

the application of the Kety–Renkin–Crone equation of capillary physiology:<br />

E =1–e PS/F (2.2)<br />

The major drawback of the BUI is its limited sensitivity for measurement of compounds<br />

with low extraction.<br />

Sensitivity was improved by at least two orders of magnitude with the internal carotid<br />

artery perfusion technique [43].An outline of the method is given in Figure 2.4. Here, the extraction<br />

can be measured over a time frame of 15 s to 10 min or more, while maintaining the

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!